Polyclonal Rabbit anti‑Human PXN / Paxillin Antibody (phospho‑Tyr88, IHC, WB) LS‑C380820
Polyclonal Rabbit anti‑Human PXN / Paxillin Antibody (phospho‑Tyr88, IHC, WB) LS‑C380820
Antibody:
PXN / Paxillin Rabbit anti-Human Polyclonal (pTyr88) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Overview
Antibody:
PXN / Paxillin Rabbit anti-Human Polyclonal (pTyr88) Antibody
Application:
IHC, WB, ELISA
Format:
Unconjugated, Unmodified
Specifications
Description
Paxillin antibody LS-C380820 is an unconjugated rabbit polyclonal antibody to human Paxillin (PXN) (pTyr88). Validated for ELISA, IHC and WB.
Target
Human PXN / Paxillin
Reactivity
Human
(tested or 100% immunogen sequence identity)
Conjugations
Unconjugated
Purification
Immunoaffinity purified
Specificity
Phospho-Paxillin (Y88) Polyclonal Antibody detects endogenous levels of Paxillin protein only when phosphorylated at Y88.
Applications
- IHC (1:100 - 1:300)
- Western blot (1:500 - 1:2000)
- ELISA (1:10000)
|
Performing IHC? See our complete line of Immunohistochemistry Reagents including antigen retrieval solutions, blocking agents
ABC Detection Kits and polymers, biotinylated secondary antibodies, substrates and more.
|
Presentation
PBS, 0.02% Sodium Azide, 50% Glycerol, 0.5% BSA
Storage
Store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human, Mouse, Rat
Applications:
IHC, IHC - Paraffin, Western blot, Immunoprecipitation
Species:
Human
Applications:
IHC, Western blot, ELISA
Species:
Human, Mouse, Rat
Applications:
Western blot
Species:
Human, Mouse, Rat
Applications:
Western blot, ELISA
Source:
E. coli
Tag:
6His, N-terminus
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 11/27/2024